Literature DB >> 10485258

A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNgamma-producing T cells.

C A Power1, C L Grand, N Ismail, N C Peters, D P Yurkowski, P A Bretscher.   

Abstract

We describe an ELISPOT technique for the detection of antigen specific IFNgamma-producing T cells. The technique is performed on spleen cells plated directly ex vivo into ELISPOT trays without an in vitro pre-culture step. Thus, the assay is likely to reflect the in vivo activity of the cells. We have found that very high cell densities (at least 10(6) cells/well) are required for optimal detection of spot forming cells, and only at a high density of cells is the number of spots detected linearly related to the number of primed cells plated. If lower numbers of antigen primed cells are used, then unprimed spleen cells from syngeneic mice can be added to the well to increase the cell density. Under these conditions, we find that the number of spots is linearly proportional to the number of primed cells plated, even if these are well below a million cells/well. Experiments with MHC congenic mice indicate that the high density of spleen cells required to obtain optimal spot formation reflects a requirement for an MHC restricted function, probably efficient antigen presentation to T cells. The formation of IFNgamma spots is antigen dependent and abrogated by depleting the antigen primed cells of T cells. We conclude that this linear assay can be used to efficiently detect ex vivo antigen-specific IFNgamma-producing T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485258     DOI: 10.1016/s0022-1759(99)00074-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  23 in total

1.  Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the T helper type 2 component of the immune response to the first antigen.

Authors:  Nahed Ismail; Antony Basten; Helen Briscoe; Peter A Bretscher
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.

Authors:  H Nishikawa; K Tanida; H Ikeda; M Sakakura; Y Miyahara; T Aota; K Mukai; M Watanabe; K Kuribayashi; L J Old; H Shiku
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

3.  Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Authors:  J G Smith; X Liu; R M Kaufhold; J Clair; M J Caulfield
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

4.  Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.

Authors:  Christian Kittel; Boris Ferko; Martina Kurz; Regina Voglauer; Sabine Sereinig; Julia Romanova; Gabriela Stiegler; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.

Authors:  Jin-Won Youn; Su-Hyung Park; Jae Ho Cho; Young Chul Sung
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.

Authors:  Yalin Ren; Peizeng Yang; Bing Li; Yang Gao; Hongyan Zhou; Xiangkun Huang; Lianxiang Zhu; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

7.  Development of Th1 imprints to rBCG expressing a foreign protein: implications for vaccination against HIV-1 and diverse influenza strains.

Authors:  Carl Power; Travis W Marfleet; Louis Qualtiere; Wei Xiao; Peter Bretscher
Journal:  J Biomed Biotechnol       Date:  2010-06-07

8.  Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene.

Authors:  So Young Choi; You Suk Suh; Jae Ho Cho; Hyun Tak Jin; Jun Chang; Young Chul Sung
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

9.  Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

Authors:  Rama Rao Amara; Francois Villinger; Silvija I Staprans; John D Altman; David C Montefiori; Natalia L Kozyr; Yan Xu; Linda S Wyatt; Patricia L Earl; James G Herndon; Harold M McClure; Bernard Moss; Harriet L Robinson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.

Authors:  Nahed Ismail; Emily C Crossley; Heather L Stevenson; David H Walker
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.